Renaissance Technologies LLC Sells 13,000 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Renaissance Technologies LLC lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 10.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 109,700 shares of the company’s stock after selling 13,000 shares during the quarter. Renaissance Technologies LLC’s holdings in Addus HomeCare were worth $13,751,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Smartleaf Asset Management LLC grew its holdings in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $77,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $86,000. Finally, KBC Group NV increased its holdings in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $102.17 on Tuesday. The stock has a market cap of $1.86 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The stock has a 50-day moving average of $100.73 and a 200-day moving average of $117.77. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have commented on ADUS shares. Stephens reiterated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. JMP Securities reissued a “market outperform” rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Thursday, April 10th. Oppenheimer upped their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.